# Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations

> **NCT06849115** · PHASE4 · COMPLETED · sponsor: **ChaodongWang** · enrollment: 4 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DRUG:** L-Carnitine Injection，1000mg once daily

## Key facts

- **NCT ID:** NCT06849115
- **Lead sponsor:** ChaodongWang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-18
- **Primary completion:** 2024-12-19
- **Final completion:** 2025-02-13
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06849115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06849115, "Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06849115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*